Simposi
New Insights On Osteoporotic Drugs And Future Therapeutic Prospectives
28 ottobre 2017 / 11.00-12.00
| 203 |
Denosumab: not only postmenopausal osteoporosis Maurizio Rossini (Verona) |
| 204 |
Antiosteoporotic drugs use reduction in Sicily during the years 2013- 2016: a medical choice or an health policy measures consequence? Vincenzo Arcoraci (Messina) |
| 205 |
Antisclerostin Antibody Marco Atteritano (Messina) |
| 206 |
Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis Alessandra Bitto (Messina) |